Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    12771251 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Citalopram to Enhance Cognition in HD
Conditions: Huntington Disease;   Chorea;   Executive Dysfunction
Interventions: Drug: 20mg daily citalopram;   Drug: Placebo

Indicates status has not been verified in more than two years